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The factors involved in pre-mRNA splicing have been tor 2 (ASF/SF2), heterogeneous nuclear ribonucleoprotein studied extensively in recent years. Alternative splicing factor/ A2 (hnRNP A2) and the 65 kDa subunit of U2 small nuclear splicing factor 2 (ASF/SF2) (7,8) is known to be an essential ribonucleoprotein particles auxiliary factor (U2AF 65 ), were factor for constitutive and alternative splicing of pre-mRNA. examined by northern blotting in a two-step chemical
It is a member of the SR protein family (9) and contains a transformation model. This in vitro model is composed of RNA-binding domain (RBD) at the N-terminus and a region BALB/3T3 cells and a BALB/3T3-derived N-methylrich in arginine and serine residues (RS domain) at the N-nitro-N-nitrosoguanidine (MNNG)-initiated cell line C-terminus. The heterogeneous nuclear ribonucleoprotein (MT-5). MT-5 cells can be transformed on exposure to 12-(hnRNP) protein A2 (10) is similar to A1 and belongs to the O-tetradecanoylphorbol-13-acetate (TPA). ASF/SF2 mRNA basic protein subset of the hnRNP complex in mammalian levels were decreased 2-fold in both MNNG-initiated cells cells. ASF/SF2 and hnRNP A1 regulate alternative pre-mRNA and TPA-induced transformed cells compared with the norsplicing through antagonistic effects on 5Ј splice sites selection mal parental cells, whereas hnRNP A2 mRNA expression in a concentration-dependent manner in vitro and in vivo. An did not significantly change between these three types of excess of hnRNP A1 favors the use of distal 5Ј splice sites, cells. U2AF 65 mRNA levels were markedly increased (~4.7-whereas an excess of ASF/SF2 promotes the use of proximal fold) associated with progression of cellular transformation.
5Ј splice sites (11,12). In addition, hnRNP A2, which has 68% Moreover, RT-PCR analysis showed that distinct forms of amino acid identity with hnRNP A1, was shown to have ASF/SF2 mRNA were present in the MNNG-initiated cells stronger 5Ј splice site switching activity than hnRNP A1 (13). and TPA-induced transformed cells but not in the parental U2 small nuclear ribonucleoprotein particles auxiliary factor cells. These findings indicate that ASF/SF2 or U2AF 65 gene (U2AF) has also been extensively characterized and shown to expression is altered during in vitro two-step chemical transplay an important role in RNA splicing (14) . U2AF is composed formation. The data suggest that the differential expression of two subunits, a 65 kDa protein (U2AF 65 ) and an associated of splicing regulatory factors is one cause of aberrant expres-35 kDa protein. Of these two polypeptides, U2AF 65 binds to sion of alternatively spliced mRNAs encoded by various the pyrimidine tract at the 3Ј splice site and is required for genes in tumor cells.
in vitro splicing of two model pre-mRNA substrates (15) . These splicing regulatory factors are necessary not only for constitutive splicing, but also for selection of alternative splice sites. The mechanisms of tumor-specific alternative pre-mRNA The splicing of pre-mRNA is a fundamental mechanism in the splicing occurring during tumorigenesis have not been thorexpression of most eukaryotic genes encoding functional oughly investigated. Thus, studies on the regulation of these proteins. In the case of alternative splicing, flexibility in the splicing regulatory factor genes during neoplastic transformaselection of splice sites is important in increasing the coding tion are needed. It was previously reported that MT-5 cells, capacity of genes and allows for the generation of several established as a mouse fibroblast BALB/3T3-derived N-methylprotein isoforms from one gene. Alternative pre-mRNA NЈ-nitro-N-nitrosoguanidine (MNNG)-initiated cell clone, splicing occurring in many genes is controlled in a tissuecould be chemically transformed on exposure to 12-O-tetradespecific or developmental-specific manner (1,2). Recently, the canoylphorbol-13-acetate (TPA) and form colonies in soft agar expression of alternatively spliced mRNAs encoding a variety medium (16) . A series of normal and transformed mouse of altered forms of proteins, such as growth factors, products fibroblasts, such as parental BALB/3T3 cells (17) and MT-5 to determine whether differential expression of one or more labeled with [ 32 P]dCTP by random priming in a solution of 50% formamide, 5ϫ standard saline citrate (SSC), 5ϫ of these splicing regulatory factors is associated with two-step chemical transformation in vitro.
Denhardt's solution, 0.1% SDS and 50 µg/ml salmon sperm DNA at 43°C for 16 h. The membranes were washed in 2ϫ BALB/3T3 cells were obtained from the Cancer Cell Repository (CCR) of Tohoku University (Sendai, Japan) and MT-5 SSC containing 0.1% SDS at room temperature for 15 min, 0.5ϫ SSC containing 0.1% SDS at 55°C for 60 min and 0.1ϫ cells were obtained from the Riken Cell Bank (Tsukuba, Japan). All cell lines were cultured in Eagle's minimum SSC at room temperature for 10 min, respectively. Analysis of densitometry was performed with a microdensitometer essential medium (Gibco BRL, Grand Island, NY) supplemented with 10% newborn calf serum (Gibco BRL), penicillin PDM-5 (Konica, Tokyo, Japan). The MNNG-initiated cells and TPA-induced transformed (100 U/ml) and streptomycin (100 µg/ml) at 37°C in a humidified atmosphere containing 5% CO 2 . MT-5 cells were cells showed a 2-fold decrease in ASF/SF2 mRNA expression as compared with the parental cells ( Figure 1A ), whereas the grown in the presence or absence of TPA. MT-5 cells exposed to 100 ng/ml TPA (Sigma, St Louis, MO) for~2 weeks showed level of hnRNP A2 mRNA did not differ significantly between the parental cells, the MNNG-initiated cells and the TPAmorphological changes and had a cobblestone-like appearance (data not shown). Total RNA was isolated from cells at induced transformed cells ( Figure 1B) . These results suggest that down-regulation of ASF/SF2 expression caused inactiva-80-90% confluency using a RNeasy kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. tion of 5Ј proximal splice site selection in the initiation step of the chemical transformation process. Another splicing Northern blot analysis was performed in the parental cells (BALB/3T3 cells), MNNG-initiated cells (MT-5 cells without factor we examined was U2AF 65 . U2AF 65 is important in the definition of 3Ј splice sites at the earliest stage of spliceosome TPA) and TPA-induced transformed cells (MT-5 cells with TPA) to test whether gene expression of ASF/SF2, hnRNP A2 assembly (18, 19) . The level of U2AF 65 mRNA was markedly increased associated with the process of two-step chemical and U2AF 65 were changed during the process of two-step chemical transformation. Twenty micrograms each of total transformation. The MNNG-initiated cells showed a 2.6-fold increase in U2AF 65 expression relative to the parental cells RNA were denatured using glyoxal and electrophoresed in 1% agarose gels, then transferred to Hybond-N ϩ nylon membranes and the TPA-induced transformed cells showed a 4.7-fold increase relative to the parental cells (Figure 2 ). These findings (Amersham, Little Chalfont, UK). The cDNA fragments for mouse ASF/SF2, hnRNP A2 and U2AF 65 were molecularly suggest that step-up activation of recognition of the 3Ј splice sites, together with activities of other splicing regulatory cloned by RT-PCR (described below). PCR primers were designed using the primer selection program OLIGO™ factors, affects the alternative splicing system and may contribute to phenotypic changes in the parental cells during (National Biosciences, Plymouth, MN). Primer sequences were as follows: ASF/SF2, 5Ј-TGAGGCAGGTGATGTATGTTA-3Ј tumorigenesis.
Mouse ASF/SF2 pre-mRNA contains a 196 bp alternative and 5Ј-GGGGAATGTAGATGTTAGGAG-3Ј; hnRNP A2, 5Ј-TGGCTTTGTTACTTTTGATGA-3Ј and 5Ј-TTCTGTTAintron and a distinct form of mRNA, designated ASF-3 mRNA, was generated by retention of this alternative intron in the CCTCTGGGCTCTC-3Ј; U2AF 65 , 5Ј-TACTGAGGAGGC-TATGATGGA-3Ј and 5Ј-ACAGGTGTCTGATTGATGGprocess of alternative splicing. If the alternative intron is not removed from the ASF/SF2 pre-mRNA, the protein product TG-3Ј. The amplified products were excised from the gel and purified using Qiaex II (Qiagen). DNA sequences of the would be truncated at a termination codon encountered near the 5Ј-end of the intron (7). ASF-3 protein, a truncated form amplified fragments were confirmed and the fragments used as probes. The membranes were hybridized with the probes of ASF/SF2 protein, thus shares the RBD with ASF/SF2 but
Splicing factors in chemically transformed cells
role, but these results raise the possibility that this isoform is involved in neoplastic transformation. To determine whether ASF-3 protein has some function during neoplastic transformation or not, further studies are needed. We have shown that altered gene expression of splicing regulatory factors occurs during two-step chemical transformation in our in vitro model. It is not known whether decreases in ASF/SF2 expression or increases in U2AF 65 expression actually alter the alternative splicing pattern of any genes in the cells during our two-step cellular transformation. However, previous in vivo experiments indicated that overexpression of splicing factors, such as U2AF (23) or ASF/SF2 (24) , influences the selection of alternative splice sites in some genes. Our results support the hypothesis that the alternatively spliced mRNAs of various genes commonly expressed in tumor tissues may be caused by differential expression of splicing regulatory factors and give a clue as to the nature of tumor-specific alternative splicing. In addition, our findings suggest that gene expression of ASF-3 participates in tumor progression. It ive splicing occurring in neoplastic transformation may help to elucidate the cause of abnormal gene expression in cancer. known whether ASF-3 protein is active or has some functional
